Ginger supplementation, coupled with an anti-inflammatory diet, has been shown to be effective in reducing nonalcoholic fatty liver disease (NAFLD) in children.
Oral supplementation of l-glutamine prevents the progression of non-alcoholic steatohepatitis (NASH), reports a recent study in the Journal of Nutrition.
The ratio of serum iron to ferritin — a blood cell protein that stores iron — can accurately predict body composition and fatty liver risk in young adult women, but not middle-aged women.
Milk fortified with phytosterols not only helped lower low-density lipoprotein cholesterol (LDL-C) in rats with non-alcoholic fatty liver disease (NAFLD), but also decreased fatty liver build-up, a study found.
New meta-analysis from China “provides substantial evidence” that n-3 polyunsaturated fatty acid (PUFA) supplementation, especially DHA, can play a positive role in the treatment of non-alcoholic fatty liver disease (NAFLD).
Treatment with green tea extract (GTE) has been found to reduce hepatic inflammation in mice with the fatty liver disease, non-alcoholic steatohepatitis (NASH).